Biomm S.A. is a Brazilian biotechnology company located in Nova Lima, in the metropolitan region of Belo Horizonte, MG. Founded in 2001, it was created as a result of a partial split from a global insulin producer. Biomm is the first and only Brazilian company entirely focused on biotechnology. Their factory is equipped with state-of-the-art technology for the production of biomedicines. The company aims to provide Brazil with independent production of high-tech medicines, such as insulin analogs and other biological medications. Biomm has an experienced technical team and an executive team that stays connected with market advancements. Over the past two decades, they have registered more than 20 patents and gained significant international experience. Biomm's main products include GHEMAXAN, AFREZZA, GLARGILIN, WOSULIN N, WOSULIN R, CANETA LIFEPEN G PARA APLICAÇÃO DE INSULINA, and HERZUMA.
Headquarters
Avenida Regent, N 705, Lote 15 Ao 21, Alphaville
Nova Lima; Minas Gerais;
Postal Code: 34018000
Contact Details: Purchase the Biomm S.A. report to view the information.
Website: http://www.biomm.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service